MEK Is a Therapeutic and Chemopreventative Target in Squamous Cell Carcinoma

Saved in:

Bibliographic Details
Published in	Journal of investigative dermatology Vol. 136; no. 9; pp. 1920 - 1924
Main Authors	Adelmann, Charles H., Truong, Kimberly A., Liang, Roger J., Bansal, Varun, Gandee, Leah, Saporito, Rachael C., Lee, Woojin, Du, Lili, Nicholas, Courtney, Napoli, Marco, Mino, Barbara, South, Andrew P., Proby, Charlotte M., Leigh, Irene M., Coarfa, Cristian, Flores, Elsa R., Tsai, Kenneth Y.
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.09.2016
Subjects	Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Apoptosis - drug effects Azetidines - pharmacology Azetidines - therapeutic use Carcinoma, Squamous Cell - drug therapy Cell Line, Tumor Cellular Senescence - drug effects Humans Mitogen-Activated Protein Kinases - antagonists & inhibitors Molecular Targeted Therapy - methods Piperidines - pharmacology Piperidines - therapeutic use Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Pyridones - pharmacology Pyridones - therapeutic use Pyrimidinones - pharmacology Pyrimidinones - therapeutic use Skin Neoplasms - drug therapy Xenograft Model Antitumor Assays cuSCC MEK MEKi ERK
Online Access	Get full text
ISSN	0022-202X 1523-1747 1523-1747
DOI	10.1016/j.jid.2016.05.110

More Information
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23
ISSN:	0022-202X 1523-1747 1523-1747
DOI:	10.1016/j.jid.2016.05.110